⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)

Official Title: Long-term Prophylaxis of Venous Thromboembolism With Low-molecular-weight Heparin in Patients With Metastatic Lung Cancer

Study ID: NCT03090880

Interventions

Tinzaparin Sodium

Study Description

Brief Summary: Prospective randomized open multicenter trial with blinded adjudication of endpoints to assess the efficacy of six-month low-dose LMWH (Low Molecular Weight Heparin) for the prevention of symptomatic or incidental VTE in patients with stage IV lung cancer and elevated D-dimer.

Detailed Description: Adult patients aged ≥ 18 years with stage IV lung cancer and elevated D-dimer will be randomized to the experimental or control group.Patients in the control group will receive usual care, patients in the experimental group will receive subcutaneous tinzaparin once daily for six months. Follow-up visit will take place in outpatient clinic at day 90, day 180 and day 360. Blood sampling for biomarkers will be performed at inclusion visit and day 90.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Hôpital Pontchaillou, Rennes, Bretagne, France

Centre Hospitalier régional d'Orléans, Orléans, Centre, France

Centre Oscar Lambret, Lille, Hauts De France, France

Hôpital Avicenne, Hôpitaux universitaires Paris Seine-, Bobigny, Ile De France, France

Hôpital d'Instruction des Armées Percy, Clamart, Ile De France, France

Hôpital Louis Mourier, Colombes, Ile De France, France

Centre Hospitalier Intercommunal de Créteil, Créteil, Ile De France, France

Centre Hospitalier de Versailles André Mignot, Le Chesnay, Ile De France, France

Hôpital Bicêtre, Le Kremlin Bicêtre, Ile De France, France

Institut Curie, Paris, Ile De France, France

Hôpital Pitié Salpétrière, Paris, Ile De France, France

Centre Hospitalier Paris Saint-Joseph, Paris, Ile De France, France

Institut Mutualiste Montsouris, Paris, Ile De France, France

Hôpital Européen Georges Pompidou, Paris, Ile De France, France

Hôpital Bichat Claude Bernard, Paris, Ile De France, France

Hôpital Tenon, Paris, Ile De France, France

Centre cardiologique du Nord, Saint Denis, Ile De France, France

Hôpital Foch, Suresnes, Ile De France, France

Gustave Roussy, Villejuif, Ile De France, France

Hôpital Larrey, Toulouse, Languedoc-Roussillon-Midi-Pyrénées, France

CHU de Caen, Caen, Normandie, France

CHU Poitiers, Poitiers, Nouvelle-Aquitaine, France

Institut de cancérologie de l'Ouest, Saint Herblain, Pays De La Loire, France

Centre Hospitalier Annecy Genevois, Annecy, Rhône Alpes, France

Groupement Hospitalier Est Hospices civils de Lyon, Lyon, Rhônes Alpes, France

Institut de Cancérologie Lucien Neuwirth, Saint Priest, Rhônes-Alpes, France

CHU de Rouen, Hôpital Charles Nicolle, Rouen, Seine Maritime, France

Contact Details

Name: Guy Meyer, MD

Affiliation: Assistance Publique - Hôpitaux de Paris

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: